NNM Securities

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2366.00-17.8 (-0.75 %)

PREV CLOSE ( ) 2383.80

OPEN PRICE ( ) 2381.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 10425

TODAY'S LOW / HIGH ( )2356.85 2420.00

52 WK LOW / HIGH ( )1240.75 2488.65

NSE2364.40-12.6 (-0.53 %)

PREV CLOSE( ) 2377.00

OPEN PRICE ( ) 2404.00

BID PRICE (QTY) 2364.40 (49)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 231691

TODAY'S LOW / HIGH( ) 2356.00 2420.00

52 WK LOW / HIGH ( )1242 2490

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 03-07 1991

Management Info

Ramesh Juneja - Chairman Rajeev Juneja - Managing Director

Registered Office

Address 208,Okhla Industrial Estate,Phase - 111,
New Delhi,
Delhi-110020

Phone 011-46846700

Email investors@mankindpharma.com

Website www.mankindpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

14Mar Mankind Pharma informs about investor
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

12Mar Rail Vikas Nigam, NBCC and Mankind Pha
Rail Vikas Nigam has emerged as the Lowest Bidder (L1) from Central Rail..

12Mar Mankind Pharma inches up on inking pac
Mankind Pharma is currently trading at Rs. 2165.60, up by 3.30 points or..

11Mar Mankind Pharma inks pact with AstraZen
Mankind Pharma has entered into an agreement with AstraZeneca Pharma Ind..

11Mar Mankind Pharma informs about press rel
Mankind Pharma has informed that Mankind Pharma & AstraZeneca Pharma..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	4870.74	12482.57
Gross Profit	5763.52	15628.36
Operating Profit	6703.4	18601.64
Net Sales	23585.66	81271.53

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 7600.75 (5.52%)	M.Cap (Rs. in Cr)9751.68
Procter&Gamble Healt (BSE) 4916.35 (2.97%)	M.Cap (Rs. in Cr)8160.84
Abbott India (BSE) 26415.75 (0.53%)	M.Cap (Rs. in Cr)56131.62
Pfizer (BSE) 4253.30 (1.13%)	M.Cap (Rs. in Cr)19457.88
Sanofi India (BSE) 8324.10 (0.51%)	M.Cap (Rs. in Cr)19170.92

Shareholding Pattern

	PROMOTERS	74.88%
	MUTUAL FUNDS/UTI	8.57%
	NON-INSTITUTION	4.11%
	FI/BANKS/INSURANCE	2.17%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Invesco India Focus...	5.28
SBI Healthcare Opp ...	5.26
ITI Pharma & Health...	5.15
Bandhan Focused Equ...	4.90
Edelweiss Recently ...	4.29
Kotak Healthcare Fu...	3.64
ICICI Pru Pharma He...	3.38

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

MANKIND PHARMA LTD.

Filing compliant on SCORES – Easy & quick